The Effects of Selective Serotonin-Reuptake Inhibitor on Visual Evoked Potential in Rats

Journal of Pharmacological Sciences

Volumn 94, Issue 3, 2004, Pages 271-276

  Iwamura, Yoshihiro ^a   Fujii, Yoko ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Fluvoxamine; Paroxetine; Serotonin; Visual evoked potential

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANPIRTOLINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; EVOKED VISUAL RESPONSE; MALE; NONHUMAN; RAT; RECEPTOR INTRINSIC ACTIVITY; REDUCTION;

EID: 1842732517     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.94.271     Document Type: Article

References (24)

1. 1-antagonists on visual evoked potential in rats. Brain Res Bull. 2003;61:393-398.
2. Plonk J, Feldman J. Modification of adrenal function by the anti-serotonin agent cyproheptadine. J Clin Endocrinol Metab. 1976;42:291-295.
3. Marks GA, Speciale SG, Cobbey K, Roffwarg HP. Serotonergic inhibition of the dorsal lateral geniculate nucleus. Brain Res. 1987;418:76-84.
4. Ying SW, Zhang DX, Rusak B. Effects of serotonin agonists and melatonin on photic responses of hamster intergeniculate leaflet neurons. Brain Res. 1993;628:8-16.
5. Rhoades RW, Bennett-Clarke CA, Shi MY, Mooney RD. Effects of 5-HT on thalamocortical synaptic transmission in the developing rat. J Neurophysiol. 1994;72:2438-2450.
6. Schmitt JAJ, Riedel WJ, Vuurman EFPM, Kruizinga M, Ramaekers JG. Modulation of the Critical Flicker Fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes. Psychopharmacology (Berl). 2002;160:381-386.
7. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1982.
8. Fleming DE, Shearer DE, Creel DJ. Effect of pharmacologically-induced arousal on the evoked potential in the unanesthetized rat. Pharmacol Biochem Behav. 1974;2:187-192.
9. Strahlendorf JCR, Goldstein FJ, Rossi GV, Malseed RT. Differential effects of LSD serotonin and l-tryptophan on visually evoked responses. Pharmacol Biochem Behav. 1982;16:51-55.
10. Hoffman BB. Catecholamines, sympathomimetic drugs, and adrenergic receptors antagonists. In: Harman JG and Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics 10th ed. New York: McGraw-Hill; 2001.
11. Albrech D, Quaschling U, Zippel U, Davidowa H. Effects of dopamine on neurons of the lateral geniculate nucleus: an iontophoretic study. Synapse. 1996;23:70-78.
12. Ducati A, Fava E, Motti ED. Neuronal generators of the visual evoked potentials: intracerebral recording in awake humans. Electroencephalogr Clin Neurophysiol. 1988;71:89-99.
13. Kraut MA, Arezzo JC, Vaughan HG Jr. Inhibitory processes in the flash evoked potential of the monkey. Electroencephalogr Clin Neurophysiol. 1990;76:440-452.
14. Eells JT, Wilkison DM. Effects of intraocular mescaline and LSD on visual-evoked responses in the rat. Pharmacol Biochem Behav. 1989;32:191-196.
15. Shearer DE, Fleming DE, Bigler ED. The photically evoked afterdischarge: a model for the study of drugs useful in the treatment of petit mal epilepsy. Epilepsia. 1976;17:429-435.
16. Bigler ED, Eidelberg E. Principal cells in lateral geniculate: effects of metrazol on capacity to after-discharge. Brain Res Bull. 1976;1:485-487.
17. Hagihara K, Tsumoto T, Sato H, Hata Y. Actions of excitatory amino acid antagonists on geniculo-cortical transmission in the cat's visual cortex. Exp Brain Res. 1988;69:407-416.
18. Schmidt M. Mediation of visual responses in the nucleus of the optic tract in cats and rats by excitatory amino acid receptors. Neurosci Res. 1991;12:111-121.
19. Maura G, Raiteri M. Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro. J Neurochem. 1996;66:203-209.
20. Mauler F, Fahrig T, Horváth E, Jork R. Inhibition of evoked glutamate release by the neuroprotective 5-HT1A receptor agonist BAY × 3702 in vitro and in vivo. Brain Res. 2001;888:150-157.
21. Schlicker E, Werner U, Hamon M, et al. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. Br J Pharmacol. 1992;105:732-738.
22. Wada Y, Hasegawa H, Nakamura M, Yamaguchi N. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neurosci Lett. 1992;138:115-118.
23. Anyanwu E, Harding GF, Edson A. The involvement of serotonin (5-hydroxytryptamine) in photosensitive epilepsy. J Basic Clin Physiol Pharmacol. 1994;5:179-206.
24. Jakälä P, Sirviö J, Koivisto E, et al. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Eur J Pharmacol. 1995;282:39-55.